DE60123276D1 - Piperazinderivate zur behandlung bakterieller infektionen - Google Patents
Piperazinderivate zur behandlung bakterieller infektionenInfo
- Publication number
- DE60123276D1 DE60123276D1 DE60123276T DE60123276T DE60123276D1 DE 60123276 D1 DE60123276 D1 DE 60123276D1 DE 60123276 T DE60123276 T DE 60123276T DE 60123276 T DE60123276 T DE 60123276T DE 60123276 D1 DE60123276 D1 DE 60123276D1
- Authority
- DE
- Germany
- Prior art keywords
- treatment
- bacterial infections
- piperazine derivatives
- derivatives
- piperazine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0031088.8A GB0031088D0 (en) | 2000-12-20 | 2000-12-20 | Medicaments |
GB0031088 | 2000-12-20 | ||
PCT/GB2001/005653 WO2002050061A1 (en) | 2000-12-20 | 2001-12-19 | Piperazine derivatives for treatment of bacterial infections |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60123276D1 true DE60123276D1 (de) | 2006-11-02 |
DE60123276T2 DE60123276T2 (de) | 2007-09-27 |
Family
ID=9905481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60123276T Expired - Fee Related DE60123276T2 (de) | 2000-12-20 | 2001-12-19 | Piperazinderivate zur behandlung bakterieller infektionen |
Country Status (9)
Country | Link |
---|---|
US (1) | US20040077655A1 (de) |
EP (1) | EP1343780B1 (de) |
JP (1) | JP2004518661A (de) |
AT (1) | ATE340171T1 (de) |
AU (1) | AU2002222287A1 (de) |
DE (1) | DE60123276T2 (de) |
ES (1) | ES2269301T3 (de) |
GB (1) | GB0031088D0 (de) |
WO (1) | WO2002050061A1 (de) |
Families Citing this family (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2417192A1 (en) | 2000-07-26 | 2002-01-31 | Smithkline Beecham P.L.C. | Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
DE60119939T2 (de) * | 2000-09-21 | 2006-11-30 | Smithkline Beecham P.L.C., Brentford | Chinolinderivate als antibakterielle mittel |
GB0031086D0 (en) * | 2000-12-20 | 2001-01-31 | Smithkline Beecham Plc | Medicaments |
GB0101577D0 (en) | 2001-01-22 | 2001-03-07 | Smithkline Beecham Plc | Compounds |
GB0112836D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
GB0112834D0 (en) * | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
US6632810B2 (en) * | 2001-06-29 | 2003-10-14 | Kowa Co., Ltd. | Cyclic diamine compound with condensed-ring groups |
WO2003004480A2 (en) * | 2001-07-02 | 2003-01-16 | Novo Nordisk A/S | Substituted piperazine and diazepanes as histamine h3 receptor agonists |
GB0118238D0 (en) * | 2001-07-26 | 2001-09-19 | Smithkline Beecham Plc | Medicaments |
AU2003239302A1 (en) | 2002-01-29 | 2003-09-02 | Glaxo Group Limited | Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them |
EP2181996A1 (de) | 2002-01-29 | 2010-05-05 | Glaxo Group Limited | Aminopiperidinderivate |
CN1172919C (zh) * | 2002-06-03 | 2004-10-27 | 上海医药工业研究院 | 芳烷醇哌嗪衍生物及其在制备抗抑郁症药物中的应用 |
TW200409637A (en) | 2002-06-26 | 2004-06-16 | Glaxo Group Ltd | Compounds |
AR040335A1 (es) | 2002-06-26 | 2005-03-30 | Glaxo Group Ltd | Compuesto de ciclohexano o ciclohexeno, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento y compuestos intermediarios de utilidad para preparar dicho compuesto |
GB0217294D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicaments |
PL375525A1 (en) * | 2002-10-10 | 2005-11-28 | Morphochem Aktiengesellschaft Für Kombinatorischechemie | Novel compounds with antibacterial activity |
ES2350977T3 (es) | 2002-11-05 | 2011-01-28 | Glaxo Group Limited | Agentes antibacterianos. |
US7232832B2 (en) * | 2002-11-05 | 2007-06-19 | Smithkline Beecham Corporation | Antibacterial agents |
US7491714B2 (en) | 2002-12-04 | 2009-02-17 | Glaxo Group Limited | Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents |
TW200507841A (en) * | 2003-03-27 | 2005-03-01 | Glaxo Group Ltd | Antibacterial agents |
CA2533824A1 (en) * | 2003-07-31 | 2005-02-10 | Irm, Llc | Bicyclic compounds and compositions as pdf inhibitors |
WO2006020561A2 (en) * | 2004-08-09 | 2006-02-23 | Glaxo Group Limited | Antibacterial agents |
GB0428327D0 (en) * | 2004-12-24 | 2005-02-02 | Astrazeneca Ab | Method |
EP1831164A1 (de) * | 2004-12-24 | 2007-09-12 | AstraZeneca AB | Heterozyklische verbindungen als ccr2b-antagonisten |
NZ590148A (en) | 2004-12-30 | 2012-04-27 | Janssen Pharmaceutica Nv | Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
EP1846417A4 (de) | 2005-01-25 | 2009-12-23 | Glaxo Group Ltd | Antibakterielle wirkstoffe |
JP2008528588A (ja) | 2005-01-25 | 2008-07-31 | グラクソ グループ リミテッド | 抗菌剤 |
US7511035B2 (en) | 2005-01-25 | 2009-03-31 | Glaxo Group Limited | Antibacterial agents |
US7709472B2 (en) | 2005-01-25 | 2010-05-04 | Glaxo Group Limited | Antibacterial agents |
JP2008528586A (ja) | 2005-01-25 | 2008-07-31 | グラクソ グループ リミテッド | 抗菌剤 |
MX2007012234A (es) | 2005-03-31 | 2008-03-18 | Johnson & Johnson | Compuestos de pirazol biciclico como agentes antibacterianos. |
JP4902247B2 (ja) * | 2005-04-08 | 2012-03-21 | 富山化学工業株式会社 | 2−(1−ベンゾチオフェン−5−イル)エタノールの新規製造法およびその中間体 |
MY150958A (en) | 2005-06-16 | 2014-03-31 | Astrazeneca Ab | Compounds for the treatment of multi-drug resistant bacterial infections |
EP2468743A1 (de) | 2005-06-24 | 2012-06-27 | Toyama Chemical Co., Ltd. | Bicyclischen Stickstoff enthaltende heterocyclische Verbindungen zur Verwendung als antibakterielle Mittel |
GB0525957D0 (en) * | 2005-12-21 | 2006-02-01 | Astrazeneca Ab | Methods |
JP2009524643A (ja) | 2006-01-26 | 2009-07-02 | アクテリオン ファーマシューティカルズ リミテッド | テトラヒドロピラン抗生物質 |
MX2008010671A (es) * | 2006-02-21 | 2008-10-01 | Amgen Inc | Derivados de cinolina como inhibidores de fosfodiesterasa 10. |
CA2643044A1 (en) * | 2006-02-28 | 2007-09-07 | Amgen Inc. | Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors |
AU2007223801A1 (en) * | 2006-03-08 | 2007-09-13 | Amgen Inc. | Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors |
JP2009532423A (ja) | 2006-04-06 | 2009-09-10 | グラクソ グループ リミテッド | 抗菌剤としてのピロロ−キノキサリノン誘導体 |
US7709496B2 (en) | 2006-04-06 | 2010-05-04 | Glaxo Group Limited | Antibacterial agents |
WO2007138974A1 (ja) | 2006-05-26 | 2007-12-06 | Toyama Chemical Co., Ltd. | 新規な複素環化合物またはその塩ならびにその中間体 |
GB0613208D0 (en) | 2006-07-03 | 2006-08-09 | Glaxo Group Ltd | Compounds |
EP1992628A1 (de) | 2007-05-18 | 2008-11-19 | Glaxo Group Limited | Derivate und Analoge von N-Ethylquinolonen und N-Ethylazaquinolonen |
KR101567096B1 (ko) * | 2007-04-20 | 2015-11-06 | 글락소 그룹 리미티드 | 항균제로서의 트리시클릭 질소 함유 화합물 |
SI2221309T1 (sl) | 2007-11-26 | 2013-10-30 | Toyama Chemical Co., Ltd. | Monohidrat derivata naftiridina |
EP2080761A1 (de) | 2008-01-18 | 2009-07-22 | Glaxo Group Limited | Verbindungen |
US20110275661A1 (en) | 2008-10-17 | 2011-11-10 | Glaxo Group Limited | Tricyclic nitrogen compounds used as antibacterials |
ES2561631T3 (es) | 2009-01-15 | 2016-02-29 | Glaxo Group Limited | Compuestos de naftiridin-2(1H)-ona útiles como agentes antibacterianos |
US8673920B2 (en) | 2009-05-06 | 2014-03-18 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
US20120220603A1 (en) * | 2009-09-04 | 2012-08-30 | Zalicus Pharmaceuticals Ltd. | Substituted heterocyclic derivatives for the treatment of pain and epilepsy |
EP2632465B1 (de) | 2010-10-27 | 2015-12-30 | Merck Sharp & Dohme Corp. | Inhibitoren des renalen kaliumkanals der äusseren medulla |
US9056859B2 (en) | 2010-10-29 | 2015-06-16 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
GB201106817D0 (en) | 2011-04-21 | 2011-06-01 | Astex Therapeutics Ltd | New compound |
RU2014110401A (ru) | 2011-08-19 | 2015-09-27 | Мерк Шарп И Доум Корп. | Ингибиторы внешнего медуллярного калиевого канала почек |
EP2755656B1 (de) | 2011-09-16 | 2016-09-07 | Merck Sharp & Dohme Corp. | Inhibitoren des renalen kaliumkanals der äusseren medulla |
WO2013062900A1 (en) | 2011-10-25 | 2013-05-02 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
EP2771005B1 (de) | 2011-10-25 | 2016-05-18 | Merck Sharp & Dohme Corp. | Inhibitoren des renalen kaliumkanals der äusseren medulla |
US9108947B2 (en) | 2011-10-31 | 2015-08-18 | Merck Sharp & Dohme Corp. | Inhibitors of the Renal Outer Medullary Potassium channel |
US9139585B2 (en) | 2011-10-31 | 2015-09-22 | Merck Sharp & Dohme Corp. | Inhibitors of the Renal Outer Medullary Potassium channel |
WO2013066718A2 (en) | 2011-10-31 | 2013-05-10 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
WO2013090271A1 (en) | 2011-12-16 | 2013-06-20 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
AR089929A1 (es) | 2012-02-10 | 2014-10-01 | Actelion Pharmaceuticals Ltd | Proceso para manufacturar un derivado de naftiridina |
AR092031A1 (es) | 2012-07-26 | 2015-03-18 | Merck Sharp & Dohme | Inhibidores del canal de potasio medular externo renal |
US9980973B2 (en) | 2012-10-19 | 2018-05-29 | Astex Therapeutics Limited | Bicyclic heterocycle compounds and their uses in therapy |
GB201218864D0 (en) | 2012-10-19 | 2012-12-05 | Astex Therapeutics Ltd | Bicyclic heterocycle compounds and their uses in therapy |
GB201218850D0 (en) | 2012-10-19 | 2012-12-05 | Astex Therapeutics Ltd | Bicyclic heterocycle compounds and their uses in therapy |
GB201218862D0 (en) | 2012-10-19 | 2012-12-05 | Astex Therapeutics Ltd | Bicyclic heterocycle compounds and their uses in therapy |
EP2925322B1 (de) | 2012-11-29 | 2018-10-24 | Merck Sharp & Dohme Corp. | Inhibitoren des renalen kaliumkanals der äusseren medulla |
WO2014099633A2 (en) | 2012-12-19 | 2014-06-26 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
EP2956142B1 (de) | 2013-02-18 | 2017-09-20 | Merck Sharp & Dohme Corp. | Inhibitoren des renalen kaliumkanals der äusseren medulla |
US10208023B2 (en) | 2013-03-01 | 2019-02-19 | Mark G. DeGiacomo | Heterocyclic inhibitors of the sodium channel |
US9765074B2 (en) | 2013-03-15 | 2017-09-19 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
US9751881B2 (en) | 2013-07-31 | 2017-09-05 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
NZ758528A (en) | 2013-12-20 | 2022-05-27 | Astex Therapeutics Ltd | Bicyclic heterocycle compounds and their uses in therapy |
WO2015127549A1 (en) * | 2014-02-27 | 2015-09-03 | Hassan Pajouhesh | Heterocyclic inhibitors of the sodium channel |
PE20170501A1 (es) | 2014-08-22 | 2017-04-27 | Glaxosmithkline Ip Dev Ltd | Un procedimiento que comprende compuestos que administran a un sujeto infectado con neisseria gonorrhoeae |
WO2016127358A1 (en) | 2015-02-12 | 2016-08-18 | Merck Sharp & Dohme Corp. | Inhibitors of renal outer medullary potassium channel |
TW201722965A (zh) | 2015-08-16 | 2017-07-01 | 葛蘭素史密斯克藍智慧財產發展有限公司 | 用於抗菌應用之化合物 |
WO2021076886A1 (en) | 2019-10-18 | 2021-04-22 | The Regents Of The University Of California | 3-phenylsulphonyl-quinoline derivatives as agents for treating pathogenic blood vessels disorders |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR86513E (fr) * | 1963-03-25 | 1966-02-25 | Rhone Poulenc Sa | Nouveaux dérivés de la quinoléine et leur préparation |
US5721237A (en) * | 1991-05-10 | 1998-02-24 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties |
EP0541486A1 (de) * | 1991-11-07 | 1993-05-12 | Ciba-Geigy Ag | Polycyclische Konjugate |
EP0869793A4 (de) * | 1995-11-13 | 1999-02-03 | Smithkline Beecham Corp | Hämoregulatorische verbindungen |
WO1999037635A1 (en) * | 1998-01-26 | 1999-07-29 | Smithkline Beecham Plc | Quinoline derivatives as antibacterials |
GB9822450D0 (en) * | 1998-10-14 | 1998-12-09 | Smithkline Beecham Plc | Medicaments |
GB9822440D0 (en) * | 1998-10-14 | 1998-12-09 | Smithkline Beecham Plc | Medicaments |
GB9914486D0 (en) * | 1999-06-21 | 1999-08-18 | Smithkline Beecham Plc | Medicaments |
GB9917408D0 (en) * | 1999-07-23 | 1999-09-22 | Smithkline Beecham Plc | Compounds |
GB9917406D0 (en) * | 1999-07-23 | 1999-09-22 | Smithkline Beecham Plc | Compounds |
US6403610B1 (en) * | 1999-09-17 | 2002-06-11 | Aventis Pharma S.A. | Quinolylpropylpiperidine derivatives, their preparation and the compositions which comprise them |
US6803369B1 (en) * | 2000-07-25 | 2004-10-12 | Smithkline Beecham Corporation | Compounds and methods for the treatment of neoplastic disease |
CA2417192A1 (en) * | 2000-07-26 | 2002-01-31 | Smithkline Beecham P.L.C. | Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
DE60119939T2 (de) * | 2000-09-21 | 2006-11-30 | Smithkline Beecham P.L.C., Brentford | Chinolinderivate als antibakterielle mittel |
US6603005B2 (en) * | 2000-11-15 | 2003-08-05 | Aventis Pharma S.A. | Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them |
GB0031086D0 (en) * | 2000-12-20 | 2001-01-31 | Smithkline Beecham Plc | Medicaments |
GB0101577D0 (en) * | 2001-01-22 | 2001-03-07 | Smithkline Beecham Plc | Compounds |
US6602884B2 (en) * | 2001-03-13 | 2003-08-05 | Aventis Pharma S.A. | Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them |
GB0112836D0 (en) * | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
GB0112834D0 (en) * | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
US20030203917A1 (en) * | 2001-07-25 | 2003-10-30 | Smithkline Beecham Corporation And Smithkline Beecham P.L.C. | Compounds and methods for the treatment of neoplastic disease |
GB0118238D0 (en) * | 2001-07-26 | 2001-09-19 | Smithkline Beecham Plc | Medicaments |
-
2000
- 2000-12-20 GB GBGB0031088.8A patent/GB0031088D0/en not_active Ceased
-
2001
- 2001-12-19 AU AU2002222287A patent/AU2002222287A1/en not_active Abandoned
- 2001-12-19 AT AT01271369T patent/ATE340171T1/de not_active IP Right Cessation
- 2001-12-19 EP EP01271369A patent/EP1343780B1/de not_active Expired - Lifetime
- 2001-12-19 DE DE60123276T patent/DE60123276T2/de not_active Expired - Fee Related
- 2001-12-19 ES ES01271369T patent/ES2269301T3/es not_active Expired - Lifetime
- 2001-12-19 US US10/450,884 patent/US20040077655A1/en not_active Abandoned
- 2001-12-19 WO PCT/GB2001/005653 patent/WO2002050061A1/en active IP Right Grant
- 2001-12-19 JP JP2002551557A patent/JP2004518661A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2004518661A (ja) | 2004-06-24 |
US20040077655A1 (en) | 2004-04-22 |
WO2002050061A1 (en) | 2002-06-27 |
EP1343780A1 (de) | 2003-09-17 |
AU2002222287A1 (en) | 2002-07-01 |
GB0031088D0 (en) | 2001-01-31 |
WO2002050061A8 (en) | 2002-07-25 |
ATE340171T1 (de) | 2006-10-15 |
DE60123276T2 (de) | 2007-09-27 |
EP1343780B1 (de) | 2006-09-20 |
ES2269301T3 (es) | 2007-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE340171T1 (de) | Piperazinderivate zur behandlung bakterieller infektionen | |
GB0101577D0 (en) | Compounds | |
GB9917406D0 (en) | Compounds | |
GB0118238D0 (en) | Medicaments | |
GB0112836D0 (en) | Medicaments | |
PE20001112A1 (es) | Derivados de quinolina como agentes antibacterianos | |
MXPA03000708A (es) | Aminopiperidin quinolinas y sus analogos azaisostericos con actividad antibacteriana. | |
GB0217294D0 (en) | Medicaments | |
AU2002218192A1 (en) | Quinoline derivatives as antibacterials | |
AU2003291227A8 (en) | Antibacterial agents | |
ATE304006T1 (de) | Aminopiperidinderivate als antibakterielles arzneimittel | |
TW200507841A (en) | Antibacterial agents | |
MY138285A (en) | Fab i inhibitors | |
DE60331849D1 (de) | Antibakterielle wirkstoffe | |
EA200400197A1 (ru) | Способы получения поливалентных бактериофагов для лечения бактериальных инфекций | |
ATE319473T1 (de) | Melagatran zur behandlung von entzündungen | |
DK1239861T3 (da) | Kombinationaf cyamemazin og et atypisk neuroleptikum | |
ECSP993176A (es) | Nuevos compuestos y composiciones antibacterianas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8381 | Inventor (new situation) |
Inventor name: DARTOIS, C.G.Y., BRENTFORD, MIDDLESEX, GB Inventor name: MARKWELL, ROGER EDWARD, HARLOW, ESSEX, GB Inventor name: MORVAN, MARCEL, BRENTFORD, MIDDLESEX, GB Inventor name: NADLER, G.M.G., BRENTFORD, MIDDLESEX, GB Inventor name: PEARSON, NEIL DAVID, HARLOW, ESSEX, GB |
|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |